Skip to content

Insider · CIK 0001874384

Patrick McCall

cfoofficer

Files at INAB (IN8BIO, INC.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 30, 2025INAB
IN8BIO, INC.
MOption exercise
Common Stock
+15,000$0.18$2,76667,071May 7, 2025
Apr 27, 2025INAB
IN8BIO, INC.
DDisposition to issuer
Series A Warrants (right to buy)derivative
-15,000--5,492May 7, 2025
Apr 27, 2025INAB
IN8BIO, INC.
AGrant or award
Series A Warrants (right to buy)derivative
+15,000--15,000May 7, 2025
Apr 30, 2025INAB
IN8BIO, INC.
MOption exercise
Series A Warrants (right to buy)derivative
-15,000$0.00$00May 7, 2025
Apr 27, 2025INAB
IN8BIO, INC.
DDisposition to issuer
Series B Warrants (right to buy)derivative
-20,492--0May 7, 2025
Apr 27, 2025INAB
IN8BIO, INC.
AGrant or award
Series B Warrants (right to buy)derivative
+20,492--20,492May 7, 2025
Feb 5, 2025INAB
IN8BIO, INC.
AGrant or award
Employee Stock Option (right to buy)derivative
+343,000$0.00$0343,000Feb 7, 2025
Dec 19, 2024INAB
IN8BIO, INC.
AGrant or award
Employee Stock Option (right to buy)derivative
+290,085$0.00$0290,085Dec 23, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Patrick McCall: insider trades and track record | InsiderTell